Ibandronic Acid Continues To Prevent Bone Loss Caused By Anastrozole In Women With Surgically Treated Breast Cancer

Ibandronic acid is an effective treatment option for post-menopausal women with early breast cancer that suffer from low bone mineral density caused by adjuvant anastrozole therapy, according to results from the ARIBON study presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

More: continued here

Filed under: Bones on June 10th, 2008